ULTRAVIST 300ML 50ML INJECTION

ULTRAVIST 300ML 50ML INJECTION is a radiographic contrast agent containing the active ingredient iopromide. It is utilized in diagnostic imaging procedures to enhance the visibility of blood vessels, organs, and tissues during radiographic examinations. This contrast medium is administered intravenously and aids healthcare professionals in obtaining clear and detailed images for diagnostic purposes.

Active Ingredient:

Iopromide: Iopromide is a non-ionic contrast agent that absorbs X-rays, thereby improving the contrast between various structures within the body and the surrounding tissues during radiographic imaging.

Mechanism of Action:

Upon intravenous administration, iopromide circulates through the bloodstream and selectively accumulates in the areas of interest. It absorbs X-rays and attenuates them differently from the surrounding tissues, resulting in enhanced contrast in the images obtained during radiographic examinations.

Uses:

ULTRAVIST 300ML 50ML Injection is indicated for various diagnostic imaging procedures, including:

• Angiography: To visualize blood vessels and assess blood flow within the body.
• Computed Tomography (CT) Scans: To enhance the visualization of internal organs and tissues for the diagnosis of various medical conditions.
• Contrast-enhanced Radiography: To improve the visibility of specific anatomical structures during radiographic examinations.

Dosage and Administration:

The dosage and administration of ULTRAVIST 300ML 50ML Injection depend on the specific imaging protocol, patient characteristics, and healthcare provider’s recommendation. It is typically administered intravenously, with the dosage adjusted based on factors such as the type of procedure, patient’s age, weight, and medical history.

Side Effects:

Common side effects associated with ULTRAVIST 300ML 50ML Injection may include:

• Nausea
• Vomiting
• Headache
• Flushing
• Allergic reactions (rare)
• Injection site reactions (if administered intravenously)

Precautions:

• Patients with a known hypersensitivity to iopromide or other contrast agents should avoid its use.
• Adequate hydration before and after contrast administration may help reduce the risk of adverse effects, particularly in patients with renal impairment.
• Special precautions are necessary for patients with a history of asthma, allergies, or renal dysfunction.
• Pregnant or breastfeeding women should consult their healthcare provider before undergoing imaging procedures involving ULTRAVIST 300ML 50ML Injection.

Conclusion:

ULTRAVIST 300ML 50ML Injection, containing iopromide, is a valuable contrast agent used in diagnostic imaging procedures such as angiography and CT scans. Its intravenous administration helps healthcare professionals obtain clear and detailed images, aiding in the diagnosis and management of various medical conditions.